blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1490317

EP1490317 - GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.01.2010
Database last updated on 11.09.2024
Most recent event   Tooltip15.01.2010Application deemed to be withdrawnpublished on 17.02.2010  [2010/07]
Applicant(s)For all designated states
Boehringer Ingelheim Pharmaceuticals Inc.
900 Ridgebury Road, P.O. Box 368 Ridgefield
Connecticut 06877-0368 / US
[N/P]
Former [2005/01]For all designated states
BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
900 Ridgebury Road, P.O. Box 368
Ridgefield, Connecticut 06877-0368 / US
Inventor(s)01 / BEKKALI, Y., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
02 / CARDOZO, Mario, G.
579 Miramar Avenue
San Francisco, CA 94112 / US
03 / KIRRANE, T. M., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
04 / KUZMICH, D., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road
P.O. Box 368, Ridgefield, CT 06877-0368 / US
05 / PROUDFOOT, J.R., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
06 / TAKAHASHI, H., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
07 / THOMSON, D., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
08 / WANG, J., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
09 / ZINDELL, R., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
10 / HARCKEN, C.H.J.J., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
11 / RAZAVI, H., Boehringer Ingelheim Pharm., Inc.
900 Ridgebury Road, P.O. Box 368
Ridgefield, CT 06877-0368 / US
 [2005/01]
Representative(s)Hammann, Heinz
Boehringer Ingelheim GmbH
CD-Patents
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2009/48]Hammann, Heinz
Boehringer Ingelheim GmbH CD-Patents Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2005/01]Hammann, Heinz, Dr.
c/o Boehringer Ingelheim GmbH, CD Patents
55216 Ingelheim am Rhein / DE
Application number, filing date03723790.621.03.2003
[2005/01]
WO2003US08589
Priority number, dateUS20020367801P26.03.2002         Original published format: US 367801 P
[2005/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03082787
Date:09.10.2003
Language:EN
[2003/41]
Type: A1 Application with search report 
No.:EP1490317
Date:29.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Search report(s)International search report - published on:EP09.10.2003
ClassificationIPC:C07C43/23, A61K31/085, A61P29/00, A61P27/14, C07C255/54, C07C233/65, C07D307/79, C07D213/30
[2005/01]
CPC:
C07C323/18 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/04 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P27/06 (EP); A61P27/14 (EP);
A61P27/16 (EP); A61P29/00 (EP); A61P29/02 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P35/00 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P7/00 (EP);
A61P7/08 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); A61P9/14 (EP);
C07C235/42 (EP,US); C07C251/48 (EP,US); C07C255/53 (EP,US);
C07C255/54 (EP,US); C07C317/22 (EP,US); C07C37/055 (EP,US);
C07C39/367 (EP,US); C07C39/373 (EP,US); C07C43/23 (EP,US);
C07C45/004 (EP,US); C07C45/30 (EP,US); C07C45/44 (EP,US);
C07C45/45 (EP,US); C07C45/63 (EP,US); C07C45/673 (EP,US);
C07C45/68 (EP,US); C07C45/69 (EP,US); C07C47/575 (EP,US);
C07C49/233 (EP,US); C07C49/255 (EP,US); C07C49/577 (EP,US);
C07C49/83 (EP,US); C07C49/84 (EP,US); C07C59/56 (EP,US);
C07C65/24 (EP,US); C07C2601/02 (EP,US) (-)
C-Set:
C07C37/055, C07C39/367 (US,EP);
C07C37/055, C07C39/373 (US,EP);
C07C45/004, C07C49/84 (US,EP);
C07C45/30, C07C49/255 (US,EP);
C07C45/44, C07C47/575 (US,EP);
C07C45/45, C07C49/84 (US,EP);
C07C45/63, C07C49/255 (EP,US);
C07C45/673, C07C49/255 (EP,US);
C07C45/673, C07C49/577 (EP,US);
C07C45/68, C07C49/255 (EP,US);
C07C45/69, C07C49/233 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:GLUCOCORTICOID-MIMETIKA, VERFAHREN ZU IHRER HERSTELLUNG, SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN, UND IHRE VERWENDUNGEN[2005/01]
English:GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF[2005/01]
French:MIMETIQUES DU GLUCOCORTICOIDE, PROCEDES DE FABRICATION DE CES MIMETIQUES, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS[2005/01]
Entry into regional phase26.10.2004National basic fee paid 
26.10.2004Designation fee(s) paid 
26.10.2004Examination fee paid 
Examination procedure18.09.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.10.2004Examination requested  [2004/53]
06.04.2009Despatch of a communication from the examining division (Time limit: M04)
18.08.2009Application deemed to be withdrawn, date of legal effect  [2010/07]
18.09.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/07]
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
31.03.2006Renewal fee patent year 04
02.04.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.200907   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0154528  (ICI PLC [GB]) [X] 1,2,8-15 * page 36, line 20; claims 7-10 *;
 [A]EP0311447  (FARMOS OY [FI]) [A] 1-30 * whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.